Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CERA.NS Stock Summary
In the News
CERA.NS Financial details
Company Rating
Neutral
Market Cap
92.78B
Income
2.27B
Revenue
18.64B
Book val./share
-
Cash/share
-
Dividend
50
Dividend %
0.65%
Employees
2.52K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
43.24
Forward P/E
-
PEG
8.63
P/S
5.34
P/B
8.24
P/C
-
P/FCF
-
Quick Ratio
2.35
Current Ratio
3.43
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
174.39
EPS next Y
-
EPS next Q
-
EPS this Y
38.59%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.71%
Revenue last 5Y
6.05%
Revenue Q/Q
-5.34%
EPS Q/Q
-10.58%
-
-
-
-
SMA20
0.78%
SMA50
-12.34%
SMA100
-16.5%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
39%
ROC
0.23%
Gross Margin
54%
Oper. Margin
17%
Profit Margin
12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6030.0-9740.0
52W High
-27.19%
52W Low
+17.61%
RSI
46.04
Rel Volume
0.14
Avg Volume
23.34K
Volume
3.24K
Perf Week
-4.4%
Perf Month
-5.8%
Perf Quarter
-16.67%
Perf Half Y
-21.48%
-
-
-
-
Beta
-0.083
-
-
Volatility
54.6%, 288.16%
Prev Close
0.01%
Price
7091.7
Change
-1.37%
CERA.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.03K | 931.79 | 936.57 | 1.11K | 1.39K | |
Net income per share | 88.52 | 87.08 | 77.48 | 116.18 | 161.01 | |
Operating cash flow per share | 95.67 | 99.46 | 206.06 | 75.34 | 124.86 | |
Free cash flow per share | 51.45 | 64.01 | 194.79 | 60.07 | 94.55 | |
Cash per share | 128.45 | 146.41 | 340.91 | 416.01 | 511.08 | |
Book value per share | 538.92 | 592.61 | 670.26 | 780.53 | 901.62 | |
Tangible book value per share | 545.78 | 597.59 | 678.69 | 791.12 | 909.36 | |
Share holders equity per share | 538.92 | 592.61 | 670.26 | 780.53 | 901.62 | |
Interest debt per share | 59.98 | 77.58 | 68.07 | 38.72 | 45.47 | |
Market cap | 39.02B | 30.06B | 50.82B | 64.67B | 83.28B | |
Enterprise value | 39.65B | 30.96B | 51.53B | 64.98B | 83.7B | |
P/E ratio | 33.89 | 26.54 | 50.43 | 42.8 | 39.77 | |
Price to sales ratio | 2.9 | 2.48 | 4.17 | 4.48 | 4.62 | |
POCF ratio | 31.36 | 23.24 | 18.96 | 66 | 51.28 | |
PFCF ratio | 58.32 | 36.11 | 20.06 | 82.77 | 67.72 | |
P/B Ratio | 5.57 | 3.9 | 5.83 | 6.37 | 7.1 | |
PTB ratio | 5.57 | 3.9 | 5.83 | 6.37 | 7.1 | |
EV to sales | 2.95 | 2.55 | 4.23 | 4.51 | 4.64 | |
Enterprise value over EBITDA | 19.61 | 18.17 | 31.37 | 27.42 | 25.47 | |
EV to operating cash flow | 31.87 | 23.94 | 19.23 | 66.32 | 51.54 | |
EV to free cash flow | 59.26 | 37.19 | 20.34 | 83.17 | 68.06 | |
Earnings yield | 0.03 | 0.04 | 0.02 | 0.02 | 0.03 | |
Free cash flow yield | 0.02 | 0.03 | 0.05 | 0.01 | 0.01 | |
Debt to equity | 0.1 | 0.12 | 0.09 | 0.04 | 0.05 | |
Debt to assets | 0.06 | 0.07 | 0.06 | 0.03 | 0.03 | |
Net debt to EBITDA | 0.31 | 0.53 | 0.44 | 0.13 | 0.13 | |
Current ratio | 2.02 | 2.27 | 2.42 | 2.68 | 3.24 | |
Interest coverage | 21.23 | 12.77 | 12.78 | 38.2 | 43.2 | |
Income quality | 0.69 | 0.96 | 2 | 0.47 | 0.57 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0.01 | |
Payout ratio | 0.14 | 0.3 | 0 | 0.11 | 0.22 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.12 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.46 | -0.36 | -0.05 | -0.2 | -0.24 | |
Capex to revenue | -0.04 | -0.04 | -0.01 | -0.01 | -0.02 | |
Capex to depreciation | -2.06 | -1.19 | -0.37 | -0.54 | -1.21 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.04K | 1.08K | 1.08K | 1.43K | 1.81K | |
ROIC | 0.14 | 0.12 | 0.09 | 0.13 | 0.15 | |
Return on tangible assets | 0.1 | 0.09 | 0.07 | 0.1 | 0.12 | |
Graham Net | 47 | 64.31 | 174.42 | 299.11 | 387.85 | |
Working capital | 3.73B | 4.02B | 5.27B | 7.3B | 8.8B | |
Tangible asset value | 7.1B | 7.77B | 8.83B | 10.29B | 11.83B | |
Net current asset value | 2.61B | 2.78B | 4.06B | 6.4B | 7.8B | |
Invested capital | 0.1 | 0.12 | 0.09 | 0.04 | 0.05 | |
Average receivables | 3.33B | 3.19B | 2.6B | 2.68B | 2.44B | |
Average payables | 1.06B | 1.06B | 1.27B | 1.46B | 1.71B | |
Average inventory | 2.05B | 2.29B | 2.21B | 2.47B | 3.38B | |
Days sales outstanding | 96.2 | 85.4 | 71.05 | 75.4 | 38.28 | |
Days payables outstanding | 68.96 | 64.8 | 91.49 | 72.2 | 91.59 | |
Days of inventory on hand | 129.93 | 161.18 | 116.27 | 156.85 | 169.31 | |
Receivables turnover | 3.79 | 4.27 | 5.14 | 4.84 | 9.53 | |
Payables turnover | 5.29 | 5.63 | 3.99 | 5.06 | 3.99 | |
Inventory turnover | 2.81 | 2.26 | 3.14 | 2.33 | 2.16 | |
ROE | 0.16 | 0.15 | 0.12 | 0.15 | 0.18 | |
Capex per share | -44.22 | -35.45 | -11.27 | -15.26 | -30.32 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 352.01 | 409.46 | 329.78 | 356.54 | 337.48 | |
Net income per share | 43.38 | 48.25 | 43.27 | 43.75 | 39.12 | |
Operating cash flow per share | 13.1 | 12.83 | 12.79 | 13.7 | 14.85 | |
Free cash flow per share | 13.1 | 12.83 | 12.79 | 13.7 | 14.85 | |
Cash per share | 418.44 | 511.08 | 504.47 | 564.23 | 0 | |
Book value per share | 817.17 | 901.62 | 909.78 | 938.05 | 0 | |
Tangible book value per share | 0 | 909.36 | 0 | 946.43 | 0 | |
Share holders equity per share | 817.17 | 901.62 | 909.78 | 938.05 | 0 | |
Interest debt per share | 1.1 | 42.44 | 1.02 | 37.86 | 1.21 | |
Market cap | 67.73B | 83.28B | 99.64B | 110.82B | 102.91B | |
Enterprise value | 73.17B | 83.7B | 106.2B | 111.15B | 102.91B | |
P/E ratio | 30.01 | 33.18 | 44.26 | 48.69 | 50.56 | |
Price to sales ratio | 14.79 | 15.64 | 23.23 | 23.9 | 23.45 | |
POCF ratio | 397.58 | 499.19 | 598.76 | 622.19 | 532.81 | |
PFCF ratio | 397.58 | 499.19 | 598.76 | 622.19 | 532.81 | |
P/B Ratio | 6.37 | 7.1 | 8.42 | 9.08 | 0 | |
PTB ratio | 6.37 | 7.1 | 8.42 | 9.08 | 0 | |
EV to sales | 15.98 | 15.72 | 24.76 | 23.97 | 23.45 | |
Enterprise value over EBITDA | 82.91 | 84.04 | 123.95 | 124.88 | 132.93 | |
EV to operating cash flow | 429.52 | 501.69 | 638.18 | 624.02 | 532.81 | |
EV to free cash flow | 429.52 | 501.69 | 638.18 | 624.02 | 532.81 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.05 | 0 | 0.04 | 0 | |
Debt to assets | 0 | 0.03 | 0 | 0.03 | 0 | |
Net debt to EBITDA | 6.17 | 0.42 | 7.66 | 0.37 | 0 | |
Current ratio | 0 | 3.24 | 0 | 3.43 | 0 | |
Interest coverage | 55.58 | 43.23 | 46.58 | 58.44 | 43.1 | |
Income quality | 0.3 | 0.27 | 0.3 | 0.31 | 0.38 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | -0.02 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 893.05 | 989.34 | 941.18 | 960.96 | 0 | |
ROIC | 0.05 | 0.05 | 0.04 | 0.05 | 0 | |
Return on tangible assets | 0 | 0.04 | 0 | 0.03 | 0 | |
Graham Net | 418.44 | 387.85 | 504.47 | 433.94 | 0 | |
Working capital | 5.44B | 8.8B | 6.56B | 9.38B | 0 | |
Tangible asset value | 0 | 11.83B | 0 | 12.31B | 0 | |
Net current asset value | 5.44B | 7.8B | 6.56B | 8.34B | 0 | |
Invested capital | 0 | 0.05 | 0 | 0.04 | 0 | |
Average receivables | 759.58M | 945.76M | 945.76M | 879.21M | 879.21M | |
Average payables | 647.46M | 1.03B | 1.03B | 912.21M | 912.21M | |
Average inventory | 1.84B | 1.91B | 1.91B | 1.89B | 1.89B | |
Days sales outstanding | 0 | 31.97 | 0 | 34.13 | 0 | |
Days payables outstanding | 0 | 75.1 | 0 | 75.12 | 0 | |
Days of inventory on hand | 0 | 138.82 | 0 | 155.53 | 0 | |
Receivables turnover | 0 | 2.82 | 0 | 2.64 | 0 | |
Payables turnover | 0 | 1.2 | 0 | 1.2 | 0 | |
Inventory turnover | 0 | 0.65 | 0 | 0.58 | 0 | |
ROE | 0.05 | 0.05 | 0.05 | 0.05 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CERA.NS Frequently Asked Questions
What is Cera Sanitaryware Limited stock symbol ?
Cera Sanitaryware Limited is a IN stock and trading under the symbol CERA.NS
What is Cera Sanitaryware Limited stock quote today ?
Cera Sanitaryware Limited stock price is $7091.7 today.
Is Cera Sanitaryware Limited stock public?
Yes, Cera Sanitaryware Limited is a publicly traded company.